Acadia Pharmaceuticals | ACAD - Resultado Líquido

Preço das Ações
21.96
Mudança Diária
-0.15 -0.68%
Mensal
-0.23%
Anual
49.08%
Q2 Previsão
21.49




Resultado Líquido Alterar Data
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Cara Therapeutics USD -5.53M 621K 2025-09
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Cytokinetics USD -183.03M 123.15M 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Incyte USD 299.28M 124.89M 2025-12
J&J USD 5.24B 119M 2026-03
Moderna USD -200M 625M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Prothena USD -21.59M 14.95M 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12